While at the Brownstone Institute retreat near Hartford, Connecticut this weekend, I heard Dr. Paul Marik speak on repurposed drugs. Of course, this has been one of my passions since the Ebola outbreak of 2014, with the realization that a safe and effective vaccine could not be developed fast enough for any newly emergent highly infectious disease or infectious bio-threat event.
Unfortunately, there is no interest in using repurposed drugs by our government or pharma for other disease indications such as cancer. This is despite the fact that computerized modeling, which is very sophisticated, suggests that there are many drugs for which the already licensed drug’s safety profile is well known, that would work well for varying types of cancers. Again, no profit motive, no interest. No research dollars or support. A dead end.
